SOS1 and chronic myelogenous leukemia, BCR-ABL1 positive: The mechanism of SOS1’s anti-CML effect as identified using LC-MS/MS and RNA-seq is that the low regulation of SOS1 promotes expression of SLC22A4 in CML cells.